Australian researchers have identified a promising new approach that could help stop one of the most aggressive forms of ...

Model trained on millions of protein measurements can gauge drug effectiveness in tissue samples taken from people with ...

Medicare's Molecular Diagnostic Services Program (MolDX), administered by Palmetto GBA, has proposed ending coverage for ...

AstraZeneca Plc’s breast cancer pill was approved by the U.S. Food and Drug Administration, a win for the drugmaker following ...

The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors ...

Breast cancer often grows in tissue that is unusually dense. That's why clinicians flag women with this kind of breast tissue ...

In a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, ...

Olema Pharmaceuticals gets a Hold rating again as its current valuation reflects both potential and significant execution risks. Click for an OLMA update.

Dartmouth Cancer Center breast cancer experts decode breast density: what it means, why dense breasts are challenging to read ...

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy ...

The approval opens up a “modest” market for AstraZeneca’s Etcamah, according to Leerink analysts, who nevertheless looked ...

“After so many required medical surgeries, I decided to do one for myself,” the ‘Bachelorette’ alum shared on Instagram ...